We are glad you want to connect with us! Fill out the form and we'll contact you to set up a call or meeting.
Mevia is a Gothenburg based company and an innovative partner to life science companies in solving the problem of medication non-adherence through reliable, customised and user-friendly end-to-end solutions
2014
Mevia’s journey began as a spin-off from Chalmers Technical University with a vision to solve the problem of non-adherence
2017
Mevia enters into a collaboration with Jones Healthcare Group. Aiming to bring real-time adherence cards to North-America and Europe.
2015
Mevia’s solutions were first tested in a real-world studies in the UK and Nordics. Showing great customer satisfaction and improving adherence
2020
Mevia integrates with one of the largest CROs globally enabling real-time adherence data in clinical trials, continuing its journey to be a leading adherence partner to different healthcare actors.
Mikael Sander
CEO
mikael.sander@mevia.se
Jesper Hassel
COO and founder
jesper@mevia.se
Jesper Lunger
CTO
jesper.lugner@mevia.se
Mevia is a trusted partner to Merck in a global multi-centre clinical study where they support patient adherence and safe data management
Mevia's collaborative and responsive approach enables us to improve products and services for our customers and their patients
Inger Rydin
Chairman of the board
Per Setterberg
Board member
Jonas Bergman
Board member
Caroline Pamp
Board member
Patrik Sjöstrand
Board member
Catharina Gustafsson
Board member